Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infection: A randomized, double-blind, and placebo-controlled study
Sara Momtazmanesh, Sahar Ansari, Zahra Izadi, Parnian Shobeiri, Venus Vatankhah, Arash Seifi, Fereshteh Ghiasvand, Mahboobeh Bahrami, Mohammdreza Salehi, Ahmad Ali Noorbala, Shahin Akhondzadeh
Topics & Concepts
FamotidinePlaceboCoronavirus disease 2019 (COVID-19)Randomized controlled trialMedicineCognitionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPsychologyClinical psychologyDouble blindAnesthesiaPsychiatryInternal medicineVirologyAlternative medicinePathologyDiseaseOutbreakInfectious disease (medical specialty)Mast cells and histamineLong-Term Effects of COVID-19Olfactory and Sensory Function Studies